The global recombinant human growth hormone (RHGH) market was valued at approximately USD 1.77 billion in 2024 and is projected to reach around USD 3.89 billion by 2032, representing a strong CAGR of about 10.30% over the forecast period.
As treatments for growth hormone deficiency, Turner syndrome, idiopathic short stature, and other related conditions...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek